BioMar Group A/S (CPH:BIOMAR)
108.00
+1.40 (1.31%)
At close: Jun 17, 2026
BioMar Group Market Cap
BioMar Group has a market cap or net worth of 10.85 billion as of June 18, 2026.
Market Cap
10.85B
Enterprise Value
14.49B
Revenue
16.34B
Ranking
n/a
PE Ratio
0.02
Stock Price
108.00
Market Cap Chart
Since June 2, 2026, BioMar Group's market cap has decreased from 10.86B to 10.85B, a decrease of -0.04%. That is a compound annual growth rate of -0.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 10.85B | 1.31% |
| Jun 16, 2026 | 10.71B | -1.30% |
| Jun 15, 2026 | 10.85B | 0.19% |
| Jun 12, 2026 | 10.83B | 0.75% |
| Jun 11, 2026 | 10.75B | 1.71% |
| Jun 10, 2026 | 10.57B | -2.59% |
| Jun 9, 2026 | 10.85B | - |
| Jun 8, 2026 | 10.85B | -1.82% |
| Jun 4, 2026 | 11.06B | -1.59% |
| Jun 3, 2026 | 11.23B | 3.46% |
| Jun 2, 2026 | 10.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ambu A/S | 16.40B |
| Netcompany Group | 14.38B |
| Per Aarsleff Holding | 13.91B |
| Bavarian Nordic | 13.82B |
| Aktieselskabet Schouw & Co. | 13.73B |
| GN Store Nord | 12.93B |
| Jeudan | 11.58B |
| Embla Medical | 11.43B |